Rang	Name	Position
1	Mr. Richard N. Kender B.S., M.B.A.	Interim CEO & Executive Chair
2	Dr. Matthew R. Henn Ph.D.	President & Chief Scientific Officer
3	Ms. Marella Thorell CPA	Executive VP, CFO & Treasurer
4	Mr. Thomas J. DesRosier Esq., J.D.	Executive VP, Chief Legal Officer & Secretary
5	Ms. Kelly Brady M.S.	Executive VP & COO
6	Mr. Chris McChalicher	Executive VP & CTO
7	Dr. Dennis M. Walling M.D.	Senior VP of Clinical Development & Head of Clinical Research
8	Ms. Ann Kurowski	Senior Vice President of Regulatory Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Flagship Ventures Management, Inc.	12,10%	6,73 Mio. USD
2	Vanguard Capital Management, LLC	3,08%	1,71 Mio. USD
3	Marshall Wace Asset Management Ltd	1,46%	0,81 Mio. USD
4	Vontobel Holding Ltd.	1,45%	0,81 Mio. USD
5	Susquehanna International Group, LLP	1,10%	0,61 Mio. USD
6	BlackRock Inc	1,07%	0,59 Mio. USD
7	Geode Capital Management, LLC	0,78%	0,44 Mio. USD
8	Vanguard Fiduciary Trust Co	0,41%	0,23 Mio. USD
9	State Street Corp	0,35%	0,20 Mio. USD
10	Charles Schwab Investment Management Inc	0,33%	0,18 Mio. USD
11	Lion Point Capital, LP	0,33%	0,18 Mio. USD
12	American Century Companies Inc	0,30%	0,17 Mio. USD
13	Morgan Stanley - Brokerage Accounts	0,23%	0,13 Mio. USD
14	Two Sigma Investments LLC	0,20%	0,11 Mio. USD
15	Northern Trust Corp	0,15%	0,09 Mio. USD
16	Amvescap Plc.	0,15%	0,09 Mio. USD
17	UBS Group AG	0,07%	0,04 Mio. USD
18	Barclays PLC	0,07%	0,04 Mio. USD
19	SBI Securities Co Ltd	0,04%	0,02 Mio. USD
20	SIMPLEX TRADING, LLC	0,03%	0,02 Mio. USD